Chronic progressive nephropathy (CPN) is a common agerelated degenerative-regenerative disease of the kidney that occurs in both sexes of most strains of rats. Recently, claims have been made that enhanced CPN is a mode of action for chemically induced kidney tumors in male rats and that renal tubular tumors (RTTs) induced by chemicals that concomitantly exacerbate CPN are not relevant for human cancer risk assessments. Although CPN is an observable histopathological lesion that may be modified by diet, the etiology of this disease and the mechanisms for its exacerbation by chemicals are unknown, and it fails to meet fundamental principles for defining carcinogenic modes of action and human relevance. Our comprehensive evaluation of possible relationships between exacerbated CPN and induction of RTTs in 58 carcinogenicity studies, conducted by the National Toxicology Program, in male and 11 studies in female F344 rats using 60 chemicals revealed widespread inconsistency in the claimed association. Because the proposed hypothesis lacks evidence of biological plausibility, and due to inconsistent relationships between exacerbated CPN and kidney tumor incidence in carcinogenicity studies in rats, dismissing the human relevance of kidney tumors induced by chemicals that also exacerbate CPN in rats would be wrong.
Claims have been made that enhanced chronic progressive nephropathy (CPN) is a "mode of action" for chemically induced kidney cancers in male rats and that renal tubular tumors (RTTs) induced by chemicals that concomitantly exacerbate CPN are not relevant for assessments of human cancer risk (Hard, 2002; Hard and Khan, 2004; Hard et al., 2007 Hard et al., , 2009 Hard et al., , 2011 Travlos et al., 2011) . However, this suggestion is inconsistent with the U.S. Environmental Protection Agency's (EPA) cancer risk-assessment guidelines for use of mechanistic data to delineate a cancer mode of action (U.S. EPA, 2005) . EPA defines mode of action "as a sequence of key events and processes starting with interaction of an agent with a cell, proceeding through operational and anatomical changes, and resulting in cancer formation." Further, a key event "is an empirically observable precursor step that is itself a necessary element of the mode of action." In other words, invoking a mode of action in cancer-risk assessments requires an understanding of the events and processes that are essential and necessary for tumor formation as a result of exposure to a carcinogenic agent. Without an understanding of these key events, it is not possible to determine whether processes that occur in one mammalian species (e.g., rats) may or may not occur in a different mammalian species (e.g., humans). With reference to CPN in rats, the etiology of this disease and its exacerbation by chemicals are unknown (Hard and Khan, 2004; Hard et al., 2009 Hard et al., , 2011 Travlos et al., 2011) . Although CPN is an observable histopathological lesion, it does not meet the most fundamental principle for defining a carcinogenic mode of action, i.e., the processes that result in tumor formation have not been identified or characterized.
CPN is a common degenerative-regenerative disease of the kidney that occurs in many strains of aging rats of both sexes. These lesions, which have cell-proliferation rates that are more than 10-fold higher than that of normal proximal tubule cells (Konishi and Ward, 1989; Short et al., 1989) , are also seen in control rats in toxicology studies spanning 3 months and longer. Nephropathy is characterized in the technical reports of the National Toxicology Program (NTP) and in other studies (Doi et al., 2007; Hard and Khan, 2004; Rao et al., 2001 ) as a spectrum of histopathological lesions including multifocal regeneration of renal tubular epithelium, thickening of tubule and glomerular basement membranes, tubule dilatation, tubular proteinaceous casts, chronic inflammatory cell infiltration, and interstitial fibrosis. Progression to an advanced stage of renal disease involves increasing severity of these lesions, with more extensive involvement of the renal parenchyma.
Although the causes of CPN are unknown, studies have shown that reducing protein or caloric intake reduces the toxicological sciences 128(2), 346-356 (2012) doi:10.1093/toxsci/kfs156 Advance Access publication April 26, 2012 severity of this disease (Keenan et al., 2000; Rao et al., 2001) . Because marked (severe) nephropathy was a contributor of early deaths in 2-year studies in rats (including controls) conducted by the NTP, from 1994, NTP reduced the protein content in feed provided to animals in long-term bioassays. This change in diet from NIH-07 (~24% protein) to NTP-2000 (~14.5% protein) reduced the occurrence and impact of severe nephropathy on early mortality of rats in chronic studies (Rao, 1996; Rao et al., 2001) ; survival was significantly higher and mean CPN-severity grades were significantly lower (2.62, reduced to 1.86) for male and female rats fed the NTP-2000 diet compared with rats fed the NIH-07 diet. Thus, if severe CPN causes renal tumorigenesis, it would be expected that RTTs would be commonly observed in control animals fed the high-protein NIH-07 diet. However, the rates of RTTs were low (about 1% or less) in control male F344 rats fed NIH-07 in the 2-year studies; and less than 0.5% in control female F344 rats (http://ntp.niehs.nih.gov/). Even in a lifespan study, incidences of RTTs were not increased (Solleveld et al., 1984) . Further, twofold higher rates of renal tumors in male rats than in female rats are similar to the gender differences in kidney tumor incidence and mortality in humans for all races and ethnicities ; http:// seer.cancer.gov).
Although industry-sponsored reviews of some NTP carcinogenicity studies (ethyl benzene, hydroquinone, quercetin, tert-butyl alcohol, and tetrahydrofuran) reported that there are correlations between severe CPN and increased incidences of RTTs in male rats (Bruner et al., 2010; Hard, 2002; Hard et al., 1997 Hard et al., , 2007 Hard et al., , 2011 , studies of other agents (gabapentin, dimethylacetamide, and N-methylpyrrolidone) have noted exposure-related increases in severity of CPN without induction of RTTs in male rats (Dominick et al., 1991; Malley et al., 1995 Malley et al., , 2001 . Consequently, we conducted a more thorough and comprehensive evaluation of possible associations between exacerbated CPN and induction of RTTs in carcinogenicity studies conducted by the NTP in F344 rats using 60 chemicals. Because of the potential role of dietary protein to modulate CPN severity, agents were grouped separately for studies that used the high-protein NIH-07 diet versus those that provided the lower-protein NTP-2000 diet.
MATERIALS AND METHODS
NTP's 2-year studies in F344 rats reporting increased severity of nephropathy (i.e., CPN) were identified by searching the NTP database for "severity of nephropathy" and by reviewing studies identified by Nyska et al. (1999) that showed treatment-related increases in severity of CPN. Chemicals were included in our evaluation if (1) the chemical induced a dose-related increase in severity of nephropathy; (2) severity values were provided in the NTP technical report of the carcinogenicity study; and (3) the nephropathy severity score was at least 2.5 in one or more of the dose groups. The latter factor was included to focus on studies with the most severe CPN. Fifty-eight carcinogenicity studies in male rats were identified that met these criteria. This analysis focused mainly on responses in male rats; however, data from 11 studies in female rats are included because they are also informative about the presence of any relationship between CPN severity and renal tubule neoplasia. Agents that induced RTTs in rats were identified from the NTP website (http://ntp.niehs. nih.gov/) under "summaries & associations of study results," followed by "organ sites associated with neoplasia." Studies with increased severity of CPN in F344 rats were examined for evidence of increased incidences of RTTs. Electronic copies of the NTP technical reports can be found on the NTP website at http://ntp.niehs.nih.gov/index.cfm?objectid084801F0-F43F-7B74-0BE549908B5E5C1C.
In the NTP studies, nephropathy (CPN) severity was graded by the percentage of renal parenchyma affected by this disease, expressed on a scale of one to four. Though most technical reports that provided severity grades did not specify the percentage of renal parenchyma affected by CPN for each scale value, for those that did (for example, see NTP Technical Reports no. 384, 420, 422, and 423) , kidneys with this lesion were graded by the study pathologist as minimal  1 (less than 25% of renal tubules affected); mild  2 ( 25-50%); moderate 3 ( 50-75%); or marked  4 ( 75%). For the few studies in which severity scores were not given but the terms minimal, mild, moderate, or marked were used to describe the nephropathy findings, the severity values were estimated by the authors by applying the same scale (one to four) to the number of animals in each dose group with a specified severity grade. Mean CPN severity grades for the control and dose groups are listed in Table 1 .
In the early 1990s, the NTP began examining additional sections of kidneys (approximately three to four per kidney, i.e., six to eight additional sections per animal, taken at 1-µm intervals) when small numbers of renal tubule adenomas or hyperplasias were observed in the original standard sections (midlongitudinal section from the left kidney and the cross section from the right kidney) taken from the dosed groups of rats. For these studies, the tumor incidence data are presented for the original sections and for the combined original section and multiple section evaluations. This technique was first introduced with the bioassay of toluene (Eustis et al., 1994; NTP, 1990) . The CPN-severity grades shown in Table 1 were based on evaluations from the original standard sections. The NTP technical reports do not provide or adjust nephropathy severities after multiple sectioning. Table 1 shows the CPN-severity values and the incidences of RTTs for each dose group in the 58 chemical carcinogenicity studies in male F344 rats and the 11 carcinogenicity studies in female F344 rats, totaling 60 chemicals, in this evaluation. When available, the incidences of RTTs in the original sections and the subsequent multiple sections combined are shown in parentheses. In addition, the NTP levels of evidence of carcinogenic activity (Huff, 1992) for the kidney tumor data are provided. Because different pathologists evaluated the studies listed in Table 1 over more than 20 years, the grading of CPN severity may not be identical across studies. However, in recent rediagnoses of the kidney histopathology for tetrahydrofuran and t-butyl alcohol, the mean severity grades were remarkably similar between the original diagnoses in the NTP technical reports and later evaluations (Bruner et al., 2010; Hard et al., 2011) . Thus, the severity values shown in Table 1 are considered reasonably reliable. Table 1 also distinguishes the results of studies using NIH-07 diet from later studies that provided the NTP-2000 diet.
RESULTS
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The studies on anthraquinone, mirex, and decalin had more than three dose groups. For these chemicals, results for controls and the three highest dose groups are shown. e 14-month duration because of early deaths in exposed animals due to extensive neoplasia in multiple organs. * Significantly different from tumor incidence in control rats, p  0.05. male rats given the NIH-07 diet. This finding, which is attributed to the lower protein content in the NTP-2000 diet, confirms the results of Rao et al. (2001) , who also observed significant reductions in CPN severity with the NTP-2000 diet. our results also show higher CPN severity in control rats from inhalation studies, compared with those in gavage studies. Because none of the chemicals was studied by both gavage and inhalation exposures, it is not possible to determine whether the route of exposure influenced CPN severity in chemically treated animals.
Despite differences in the CPN-severity scores, incidences of RTTs were not statistically different between the control groups fed either NIH-07 or NTP-2000 diets when data from the original kidney sections or the original sections plus multiple sections were analyzed (Table 3) . As expected, additional sections of kidneys significantly increased the incidences of RTTs (3.4-fold) in control groups given the NIH-07 diet. The substantial threefold increase in RTTs after multiple sectioning in controls given the NTP-2000 diet was not statistically significant; this is probably due to the small number of studies and the resulting large variance. Table 1 include many studies with dose groups having CPN-severity grades of 3.0 or greater without a corresponding increase in RTTs (e.g., benzofuran, C.I. Pigment Red 3, dipropylene glycol, mercaptobenzothiazole, mirex, pulegone, and toluene). In many groups with a severity grading of ~3.0, 50-60% or more of the animals commonly had marked or severe CPN. The top dose groups of C.I. Pigment Red 3, dipropylene glycol, mirex, and pulegone in male rats had some of the highest mean CPN-severity grades (3.8, 3.9, 3.9, and 4.0, respectively); however, the incidences of RTTs were not increased in those dose groups. In the highest exposure group of the mirex study, 84% of male rats were diagnosed with marked severity of CPN. Figure 1 is a plot of RTT incidence versus CPN severity for all groups of male rats (from Table 1 ) that had severity values of ≥ 3.0. one would expect most of these groups to have significantly increased incidences of RTTs if severe CPN induces or promotes RTTs in male rats. However, no clear trend or consistent response is apparent, e.g., incidences of RTTs do not increase with higher CPN-severity scores. In general, significant increases in RTTs in exposed groups compared with controls were observed, with RTT incidences of ~10% or higher. Because of variability in control groups, especially after multiple sectioning, some dose groups with high incidences of RTTs did not achieve statistical significance (e.g., see data for t-butyl alcohol in Table  1 ). Most notably, in Figure 1 , many groups with severe CPN had zero or very low (nonsignificant) incidences of RTTs.
Data in
Several chemical-specific findings from the studies listed in Table 1 Excluding multiple-section data from t-butyl alcohol study because of the unusually high control value after multiple sectioning.
FIG. 1.
Renal tubule tumor (RTT) incidence versus mean CPN severity ≥ 3.0. Numbers in parentheses indicate the number of control or dosed groups having the same incidence of RTTs and the same mean CPN severity. For chemicals that had multiple sectioning data, incidences of RTTs from the original-standard and the multiple-section evaluations were combined and included in this plot, instead of the RTT-incidence data from the standard evaluations.
*Significantly increased incidence of RTTs compared with the respective control group, p  0.05. **Two groups with significant increases in RTTs.
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(1) For anthraquinone, increased incidences of RTTs in male rats (2% in controls vs. 18, 10, and 6% in low-dose, middose, and high-dose groups, respectively) appear to occur with increased severity of CPN in the treated groups (2.2 vs. 3.1, 3.0, and 3.0%). However, the more notable increase in RTTs observed in female rats exposed to anthraquinone (0 vs. 18, 16, and 29%) does not correspond to an effect on CPN severity (1.2 vs. 1.4, 1.3, and 1.5). Results from the anthraquinone study demonstrate clearly how a misinterpretation of data might arise (i.e., attributing increases in RTTs to severity of CPN) if an explanation for the RTT response was limited to histopathology follow-up in only male rats. (2) For benzofuran, severe CPN in male rats (1.8 vs. 3.3 and 2.9) was not associated with induction of RTTs (0 vs. 0, 0%), whereas in female rats, an increase in RTTs (0 vs. 2 and 8%) was not associated with severe or marked CPN (0.7 vs. 1.7 and 1.2%). (3) In the t-butyl alcohol study, severity of CPN in male rats was similar in controls and the three dose groups (3.0 vs. 3.1, 3.1, and 3.3%), whereas the incidences of RTTs were elevated in each dose group (16 vs. 26, 38, and 26%). Most notably, the severity of CPN was increased in female rats (1.6 vs. 1.9, 2.3, and 2.9%), with the top dose having a CPN grade similar to that in male rats; however, no RTTs were observed (0 vs. 0, 0, and 0%) in female rats. (4) For ethyl benzene, increases in the incidences of RTTs in male rats (6 vs. 10, 16, and 42%) were observed at the top dose associated with severe CPN (mean severity: 3.5). as well as at doses in which CPN severity was similar to that of the control group (mean severity: 2.3 vs. 2.4 and 2.3). An increase in RTTs was also observed in female rats (0 vs. 16%), but at a dose associated with only mild to moderate CPN (mean severity: 2.3). These results show that advanced CPN (severity > 3.0) is not necessary or sufficient to observe increased kidney tumors in rats. (5) The results for tetrafluoroethylene are similar to those for anthraquinone: increases in RTTs in male rats (6 vs. 10, 18, and 26%) that correspond to increases in mean severity of CPN largely at the top dose (2.3 vs. 1.9, 2.7, and 3.5), but also increases in RTTs in female rats (0 vs. 6, 6, and 20%) without severe CPN (mean severity: 1.7 vs. 1.5, 1.7, and 2.0).
Certainly, for anthraquinone, benzofuran, t-butyl alcohol, ethyl benzene, and tetrafluoroethylene, other mechanisms of carcinogenesis must be operating. Similarly, in studies that had elevated incidences of RTTs with mostly mild to moderate CPN (cumene, dimethyl methylphosphonate, hexachloroethane, 8-methoxypsoralen, pyridine, and 1,2,3-trichloropropane), biological processes other than hypothesized severe CPN must be involved. For a compound such as chloroprene, a multisite carcinogen that is metabolized to a DNA-reactive epoxide intermediate, the flat increase in RTTs (2 vs. 16, 12, and 16%) with increasing severity of CPN (2.8 vs. 3.0, 3.1, and 3.5) does not exclude the likelihood that multiple processes are involved in the renal carcinogenicity of this agent. For isoprene, another multisite carcinogen that is metabolized to genotoxic epoxide intermediates, the clear dose-related increase in RTTs (4 vs. 8, 16, and 30%) is quite different from the very small increases in mean CPN severity in the same dose groups (2.8 vs. 2.7, 2.9, and 3.2). Several chemicals also induced tumors of the transitional epithelium of the renal pelvis in male and/or female rats (anthraquinone, dimethyl methylphosphonate, o-nitroanisole, phenylbutazone, and salicylazosulfapyridine). These findings also indicate that processes other than hypothesized severe CPN of renal tubules are involved in the kidney carcinogenicity of these agents. Table 4 presents the levels of evidence for carcinogenic activity (definitions at http://ntp.niehs.nih.gov/ index.cfm?objectid= 07027D0E-E5CB-050E-027371D9CC0AAACF#CARCDEF) for the kidney tumor results in male F344 rats for the 43 chemicals listed in Table 1 that had at least one dose group with CPN severity ≥ 3.0. For 21 of these chemicals (49%), there was clear or some evidence for carcinogenic activity (including the five chemicals reexamined by Bruner et al., 2010; Hard, 2002; and Hard et al., 1997 and Hard et al., , 2007 . For 17 chemicals (40%), there was no evidence for carcinogenic activity, whereas for 5 chemicals (12%), the evidence for carcinogenic activity was equivocal, i.e., showing marginal increases. Thus, the chance that a chemical in- duces CPN with a severity grading ≥ 3.0 and provides some or clear evidence for carcinogenic activity in the kidney, in a 2-year study in male rats is approximately 50%. Even ignoring chemicals having equivocal evidence for carcinogenic activity does not support a consistent association between severe CPN and positive evidence for carcinogenic activity in the kidney.
For at least nine chemicals presented in Table 4 that had some or clear evidence for carcinogenic activity in the kidney, the increased incidences of RTTs in the low or mid-dose groups occurred with no or very slight increases in mean CPN severity compared with their control groups or with mean CPN grades indicative of only mild to moderate severity (e.g., t-butyl alcohol, chloroprene, decalin, ethyl benzene, hydroquinone, isoprene, methyleugenol, tetrafluoroethylene, and tetrahydrofuran). The lack of comparable dose-response relationships contradicts the hypothesis that exacerbated CPN is causative of neoplastic effects in the kidney. Table 5 provides the levels of evidence for carcinogenic activity for the kidney tumor results in F344 rats for the 16 chemicals listed in Table 1 in which the highest mean CPN-severity grades were between 2.5 and 3.0 in at least one dose group. For six chemicals, there was some or clear evidence for carcinogenic activity; and for seven other chemicals, there was no evidence for carcinogenic activity based on kidney tumor data. Induction of RTTs by the six chemicals with some or clear evidence for carcinogenic activity in the kidney was associated with mean CPNseverity grades that were lower than those of chemicals in Table 4 that had no evidence for carcinogenic activity in the kidney. Thus, the renal carcinogenic activity of these chemicals must be due to processes unrelated to induction of severe CPN.
DISCUSSION
Claims by Hard and colleagues (Hard and Khan, 2004; Hard et al., 2007 Hard et al., , 2009 Hard et al., , 2011 Travlos et al., 2011) that (1) exacerbated CPN is a mode of action for renal tubule neoplasia in rats, (2) this condition is irrelevant to humans, and (3) RTTs observed in animals having severe CPN should not be used in human cancer-risk assessments lack scientific support for several reasons. CPN is not an established mode of action or mechanism of renal carcinogenicity. Neither the etiology of this kidney disease in aging control rats nor the mechanism of chemically exacerbated CPN in rats is known. Hence, there is no basis for establishing a mode of action for enhancement of CPN in rats or for defining critical biological processes that could occur in rats and presumably could not likewise occur in humans. Although cell proliferation is involved in the development of cancer, and rates of cell proliferation are approximately 10-fold higher in CPN lesions than in normal proximal tubule cells (Konishi and Ward, 1989; Short et al., 1989) , experimental studies indicate that chemically enhanced cell division does not reliably predict carcinogenicity (Melnick et al., 1993) , including studies of tumor development in the rat kidney (Ward et al., 1993) . Based on an evaluation of the potential influence of toxicity on the outcome of NTP's carcinogenicity studies, Hoel et al. (1988) concluded that histopathological findings alone cannot justify or confirm mechanistic assumptions of chemically induced tumors. Seely et al. (2002) reported a marginal association between severity of CPN and the occurrence of RTTs in control male F344 rats from 28 NTP 2-year carcinogenicity studies, although many rats in that study had severe CPN without RTT. These authors were cautious of this possible relationship for two additional reasons: (1) this strain of rat has a high incidence of CPN, yet the historical rate of RTTs in control male F344 rats is generally  1%, and (2) there are chemicals that exacerbate CPN without inducing RTTs. Consequently, Seely et al. (2002) concluded that if RTTs develop secondary to exacerbated CPN, then the number would be small, and factors other than exacerbated CPN are probably involved in chemically induced RTTs.
We examined relationships between exacerbated CPN and induction of RTTs in carcinogenicity studies conducted by NTP in F344 rats because reviews of some NTP-conducted carcinogenicity studies claimed there was a strong and causal relationship between exacerbation of CPN severity and RTT induction in male rats (Bruner et al., 2010; Hard et al., 1997 Hard et al., , 2007 Hard et al., , 2011 Travlos et al., 2011) , whereas studies of other chemicals demonstrated a clear lack of association between exposure-related increases in severity of CPN and RTTs in male rats (Dominick et al., 1991; Malley et al., 1995 Malley et al., , 2001 .
The CPN-severity grading scale used in NTP technical reports, which is based on the percentage of renal parenchyma affected by this disease, is different from the eight-point grading system of Hard and Khan (2004) , which includes the number of CPN lesions as focal changes (grades 1-5), foci beginning to coalesce (grade 6), a majority of cortical parenchyma being affected (grade 7), and end-stage renal disease (grade 8; in which no normal parenchyma is observed). As such, the two grading systems are not directly comparable. The latter grading system was used in subsequent and independent reviews of NTP carcinogenicity studies on ethyl benzene, hydroquinone, quercetin, and tetrahydrofuran (Bruner et al., 2010; Hard, 2002; Hard et al., 1997 Hard et al., , 2007 . In these papers, Hard and colleagues report that incidences of RTTs occur predominantly in rats with advanced CPN (grades 7 and 8). Conversely, in a review of the NTP study on t-butyl alcohol, Hard et al. (2011) used a fourpoint severity-grading system similar to that of NTP. In that study, most animals with a renal tumor had a severity grade of 3.0 or 4.0; the mean CPN severity was 3.5 in male rats with RTTs. Thus, to evaluate possible associations between exacerbated CPN and increased incidences of RTTs in male rats, we focused on animal groups with CPN-severity grades of ≥ 3.0 because these are the groups with the greatest number of animals with advanced CPN. In some studies, marked severity was considered a major factor contributing to reduced survival of male rats after about 90 weeks of exposure to test chemicals. As shown in Figure 1 and Table 4 , there is no clear pattern of tumor response nor is there convincing evidence for carcinogenic activity in the kidney in many groups with advanced CPN. our assessment of 60 chemicals included 58 NTP-conducted carcinogenicity studies in male F344 rats and 11 carcinogenicity studies in female F344 rats that demonstrated dose-related increases in severity of CPN and had a mean severity score of at least 2.5 in one or more of the dose groups. This evaluation shows that chemically exacerbated CPN in rats is very often not associated with increased incidences of RTTs. of the 43 studies that had at least one dose group with CPN severity ≥ 3.0, there was 'clear' or 'some' evidence for carcinogenic activity in the male rat kidney for 21 chemicals (including the five chemicals re-examined by Bruner et al., 2010; Hard, 2002; Hard et al., 1997 Hard et al., , 2007 Hard et al., , 2011 , equivocal evidence for carcinogenic activity for 6 chemicals, and no evidence for carcinogenic activity for 17 chemicals (Table 4) . Thus, the approximately 50:50 chance that a chemical induces marked CPN in a carcinogenic bioassay and demonstrates some or clear evidence for carcinogenic activity in the kidneys of male rats is about the same as picking a head or a tail when flipping a coin. A similar distribution was found for chemicals in which the highest mean CPN-severity grade was  2.5 and  3.0 in at least one dose group (Table 5 ). In addition, for many studies that resulted in 'clear' or 'some' evidence for carcinogenic activity in the male rat kidney, increased incidences of RTTs were observed with only mild to moderate mean CPN-severity grades (i.e.,  2.5) in the low or mid-dose groups. These findings certainly do not support a consistent or causal association between advanced CPN (severity  3.0) and positive evidence for carcinogenic activity in the rat kidney.
A consistent association between an essential precursor process and tumor induction is a fundamental requirement for any proposed carcinogenic mode of action. Renal carcinogens that affect cytokine signaling in the kidney might alter the pathogenesis of spontaneous aging nephropathy at doses that induce kidney tumors in rats. Consequently, correlations between exacerbated CPN and RTTs may result from early changes induced by certain renal carcinogens causing increases in the severity of CPN in 2-year carcinogenicity studies or in 90-day toxicity studies. Correlative observational studies provide no insight into the mechanistic events in renal or other organ carcinogenesis. Focusing on a single or small number of kidney carcinogens and attempting to identify prior changes that may or may not be determinants of tumor outcome cannot by itself ascertain a carcinogenic mode of action and is certainly not an adequate challenge of an untested hypothesis. Such an approach will often lead to incorrect interpretations. For example, in the cases of anthraquinone, t-butyl alcohol, and tetrafluoroethylene, induction of RTTs in male rats was observed with exacerbated CPN (severity grades  3.0). These observations might appear to support a causal relationship. However, with anthraquinone and tetrafluoroethylene, RTTs were induced in female rats without exacerbation of CPN. Such findings contradict a causal or precursor relationship between CPN and RTTs. For these two chemicals, increased severity of CPN does not provide a reliable explanation for a mechanism of RTT induction. Additionally, anthraquinone induced transitional cell tumors of the renal pelvis in male rats, certainly implying different or multiple modes of action. In the case of t-butyl alcohol, moderate to marked CPN was observed with increased incidences of RTTs in male rats (though with apparently different dose-response relationships), whereas exacerbated CPN in female rats was not associated with induction of RTTs. Hard et al. (2011) attributed this sex discrepancy to the induction of α 2 u-globulin nephropathy in male rats, which did not occur in female rats. However, this explanation is also deficient because these authors reported that the low and mid-dose groups of male rats "did not show evidence supporting an α 2 u-g mode of action" . Furthermore, Doi et al. (2007) reported a lack of consistent association between key events in α 2 u-globulin nephropathy and increases in RTTs among four NTP studies in which chemical exposures significantly increased the α 2 u-globulin concentrations in male rat kidneys. Several chemicals increased the severity of CPN in female rats to a similar degree as t-butyl alcohol in male or female rats without affecting the incidence of RTTs; these include C.I. Acid Red 114, diethanolamine, furan, mirex, phenylbutazone, and pulegone.
Results from other studies on individual chemicals further highlight inconsistencies in the proposed relationship between exacerbated CPN and RTT induction. Findings from 2-year inhalation studies of furfuryl alcohol are noteworthy because a mean CPN-severity grade of 3.7 in high-dose male rats did not produce evidence of a neoplastic effect in the kidney (0% RTTs from original sections and 8% from original and multiple sections, compared with and not different from 4% in the control group from original and multiple sections), whereas an increased incidence of rare RTTs in high-dose male mice was considered by NTP (1999) to provide some evidence for carcinogenic activity (8% incidence of RTTs from original sections and 10% from original and multiple sections, compared with 0% in the control group from original and multiple sections). The mean CPN-severity grading in high-dose male mice was only 1.8 (vs. 1.2 in controls). Furfuryl alcohol provides another example in which exacerbated CPN was not associated with an increased incidence of RTTs in male rats, whereas a neoplastic effect in the kidney of a second species (mice) was observed with mild CPN severity. Travlos et al. (2011) claimed that in 2-year studies of 24 chemicals in male rats, seven chemicals with treatment-related exacerbation of CPN demonstrated increased incidences of RTTs. They did not analyze chemicals that increased the mean severity of CPN in the 2-year studies for effects on RTT incidence as we have done in this study. Their analysis ignores the fact that one of these chemicals was anthraquinone, which induced RTTs in all the dosed groups of female rats without having an effect on CPN severity (Table 1) . A second chemical, divinylbenzene, was not included in our analysis because it had mean CPN-severity grades of 1.8 in the control group and 1.5, 2.1, and 1.8 in the three dosed groups (i.e., mild severity). A third chemical, oxymetholone (Table 1) , had mean CPN-severity grades of 2.0 in the control group and 2.6, 2.7, and 2.7 in the three dosed groups, whereas the incidence of RTTs in the mid-and top-dose groups was similar to that of the control group. Certainly, results for these three chemicals do not support the contention that induction of RTTs is simply due to severe CPN. Two of the chemicals, benzophenone and decalin, had some clear evidence of carcinogenicity in the kidney, and at least one dose group had a mean CPN-severity grade of ≥ 3.0 (Table 4) . However, for decalin, increased incidences of RTTs were also observed in dose groups with mean CPN grades indicative of only mild to moderate severity. For the other two chemicals in this group, propylene glycol mono-tbutyl ether and Stoddard solvent IIC, the RTT data were judged by NTP as equivocal evidence of carcinogenicity. In spite of these inconsistent findings, Travlos et al. (2011) concluded "that treatment-related exacerbation of CPN in 90-day studies [in male F344 rats] is a relatively common occurrence, having the potential to be predictive of an increased incidence of RTT in subsequent 2-year bioassays," which "have no relevance for species extrapolation in human risk assessment." These conclusions are not supported by data and should not be used to deter risk-assessment processes.
Potential relationships between occupational and environmental exposures to agents that cause or contribute to chronic kidney disease and/or increase in the risk of kidney cancer development in human populations with varying genetic susceptibilities have not been fully determined. occupational exposures to organic solvents have been linked to impaired renal tubular function (Franchini et al., 1983; Soderland et al., 2010; Van Vleet and Schnellmann, 2003; Voss et al., 2005) . Although the causes and mechanisms of kidney cancer in humans are not totally known, prolonged exposures to trichloroethylene (a chemical that also causes kidney tumors in rats), other organic solvents, and certain metals have been associated with increased risk of renal cell carcinoma (Buzio et al., 2002; Huff et al., 2004; Pesch et al., 2000; U.S. EPA, 2011) . Increases in renal tubular toxicity and increased incidences of renal cell cancers were observed in miners exposed 7 to 35 years to dinitrotoluene (Brüning et al., 1999 (Brüning et al., , 2001 . In humans, chronic renal fibrosis induced by Chinese herbal medications containing aristolochic acid did not lead to kidney tumors, but exposure was associated with urothelial tumors (Nortier and Vanherweghem, 2002) . Chronic renal fibrosis, a lesion observed in rat CPN, is seen in human kidneys, with uncertain associations with renal cancer (Cernaro et al., 2012; Liu, 2011) . Because kidney cancer rates in humans are increasing (Simard et al., 2012) and the reason for this increase is not fully known, it would be wrong to dismiss the relevance of kidney tumors in experimental animals for human risk assessments simply because a chemical also exacerbated CPN.
Among the 58 studies in male rats included in our review, 45 used the NIH-07 diet and 13 used the NTP-2000 diet. The mean CPN severity in the control groups of male rats was significantly lower in studies that used the NTP-2000 diet with lower protein content. This was true when comparisons were made for all routes of exposure or separately for gavage and inhalation studies. Although the effect of dietary protein on CPN severity had been reported previously (Haseman et al., 2003; Rao et al., 2001; Travlos et al., 2011) , we also found significantly lower mean CPN grades in gavage studies compared to inhalation studies with either diet. Why this occurs is not known.
In conclusion, the scientifically unsupported suggestion that exacerbated CPN is a mode of action for RTT development that renders such tumor data irrelevant to humans lacks the fundamental requirement needed to judge biological plausibility: the mechanism(s) of chemically exacerbated CPN and of RTT development are complex and generally not known. Because no key events leading to the development of CPN have been identified, it is not surprising that a mode of action for renal tubule neoplasia based on CPN exacerbation has not been delineated. A limited number of select studies reporting correlations between increased CPN severity and induction of RTTs in male rats do not provide proof of a causal relationship nor insight into the mechanistic events involved in renal carcinogenesis. The large number of chemicals that induce severe CPN but do not induce RTTs in rats points to a major deficiency in the attempts to causally link advanced CPN to RTT development: inconsistency in the proposed association. Thus, empirical evidence provides no support for the claim that exacerbated CPN is predictive of RTT induction in rats. Because kidney cancer rates in humans are increasing (Simard et al., 2012) and the causes of this disease are not fully known, it is essential, from a public health perspective, to regard environmental and occupational exposures to agents inducing kidney cancers in experimental animals as posing a carcinogenic risk to humans. This perspective is compelling whether or not the chemical exacerbates CPN to an advanced stage. 
